Molecular diagnostics platform, using proprietary technology to develop diagnostic tests for pre-natal and oncology.
Founder(s)
Oguzhan Atay, PhD and David Tsao, PhD
THEME(S)
Aligned care models
Emerging therapeutic platforms
SECTOR(S)
Healthcare
Investment Stage
Growth
Company Status
Private
Perspectives

More about Billion To One

No items found.